Log In
Print this Print this

telotristat etiprate (LX1606) (LX1032)

  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionTryptophan hydroxylase inhibitor
Molecular Target Tryptophan hydroxylase 1 (TPH1) (TPH)
Mechanism of ActionTryptophan hydroxylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat carcinoid syndrome; Treat carcinoid tumors; Treat refractory carcinoid syndrome
Regulatory Designation

U.S. - Fast Track (Treat carcinoid syndrome);
U.S. - Orphan Drug (Treat carcinoid syndrome);
EU - Orphan Drug (Treat carcinoid tumors)


Ipsen Group

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today